Search

Your search keyword '"Japanese encephalitis virus"' showing total 41 results

Search Constraints

Start Over You searched for: Descriptor "Japanese encephalitis virus" Remove constraint Descriptor: "Japanese encephalitis virus" Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
41 results on '"Japanese encephalitis virus"'

Search Results

1. Japanese encephalitis virus infection causes reactive oxygen species‐mediated skeletal muscle damage.

2. Aetiological profile of acute encephalitis syndrome in Assam, India, during a 4‐year period from 2019 to 2022.

3. Spatio‐temporal epidemiology of Japanese encephalitis virus infection in pig populations of eastern Uttar Pradesh, India, 2013–2022.

4. Novel antiviral discoveries for Japanese encephalitis virus infections through reporter virus‐based high‐throughput screening.

5. Phylogeny and spatial distribution of Japanese encephalitis virus vector species in Cambodia.

6. Antiviral and anti‐inflammatory activity of natural compounds against Japanese encephalitis virus via inhibition of NS5 protein and regulation of key immune and inflammatory signaling pathways.

7. Japanese encephalitis virus infection in meerkats (Suricata suricatta).

8. Duck Tembusu virus induces stronger cellular responses than Japanese encephalitis virus in primary duck neurons and fibroblasts.

9. Detection of coinfection of a divergent subgroup of genotype I Japanese encephalitis virus in multiple classical swine fever virus outbreaks in pigs of Assam, India.

10. Purification of cell‐derived Japanese encephalitis virus by dual‐mode chromatography.

11. Detection of Japanese encephalitis virus in mosquitoes from Xinjiang during next‐generation sequencing arboviral surveillance.

12. Inactivation of Japanese encephalitis virus in plasma by methylene blue combined with visible light and in platelet concentrates by ultraviolet C light.

13. Introduction of the Japanese encephalitis virus (JEV) in the United States – A qualitative risk assessment.

14. Memantine can relieve the neuronal impairment caused by neurotropic virus infection.

15. Detection of Japanese Encephalitis Virus in bone marrow of healthy young wild birds collected in 1997–2000 in Central Italy.

16. Exploitation of microRNAs by Japanese Encephalitis virus in human microglial cells.

17. Sublingual immunization with Japanese encephalitis virus vaccine effectively induces immunity through both cellular and humoral immune responses in mice.

18. A large outbreak of Japanese encephalitis predominantly among adults in northern region of West Bengal, India.

19. Porcine 2′, 5′-oligoadenylate synthetases inhibit Japanese encephalitis virus replication in vitro.

20. Japanese encephalitis associated acute encephalitis syndrome cases in West Bengal, India: A sero-molecular evaluation in relation to clinico-pathological spectrum.

21. Evaluation of a temperate climate mosquito, Ochlerotatus detritus (= Aedes detritus), as a potential vector of Japanese encephalitis virus.

22. RIG-I knockdown impedes neurogenesis in a murine model of Japanese encephalitis.

23. Structure-based identification of functional residues in the nucleoside-2′-O-methylase domain of Bluetongue virus VP4 capping enzyme.

24. Detection and Differentiation of Genotype I and III Japanese Encephalitis Virus in Mosquitoes by Multiplex Reverse Transcriptase-Polymerase Chain Reaction.

25. Dengue, Japanese encephalitis and Chikungunya virus antibody prevalence among captive monkey ( Macaca nemestrina) colonies of Northern Thailand.

26. Integrative effect of defective interfering RNA accumulation and helper virus attenuation is responsible for the persistent infection of Japanese encephalitis virus in BHK-21 cells.

27. Characterization of Japanese encephalitis virus infection in an immortalized mesencephalic cell line, CSM14.1.

28. A bio-nanocapsule containing envelope protein domain III of Japanese encephalitis virus protects mice against lethal Japanese encephalitis virus infection.

29. Seizures and encephalitis: Clinical features, management, and potential pathophysiologic mechanisms.

30. Seroprevalence of Japanese Encephalitis Virus and Risk Factors Associated with Seropositivity in Pigs in Four Mountain Districts in Nepal* Seroprevalence of Japanese Encephalitis Virus and Risk Factors Associated with Seropositivity in Pigs in Four Mountain Districts in Nepal

31. Enterovirus 71 encephalomyelitis and Japanese encephalitis can be distinguished by topographic distribution of inflammation and specific intraneuronal detection of viral antigen and RNA.

32. Development of an in vitro antigen-detection test as an alternative method to the in vivo plaque reduction neutralization test for the quality control of Japanese encephalitis virus vaccine.

33. Critical role of lipid rafts in virus entry and activation of phosphoinositide 3′ kinase/Akt signaling during early stages of Japanese encephalitis virus infection in neural stem/progenitor cells.

34. Evaluation of two commercially available ELISAs for the diagnosis of Japanese encephalitis applied to field samples.

35. Japanese encephalitis virus differentially modulates the induction of multiple pro-inflammatory mediators in human astrocytoma and astroglioma cell-lines

36. Japanese encephalitis virus infects neural progenitor cells and decreases their proliferation.

37. Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis.

38. Desiccated vector mosquitoes used for the surveillance of Japanese encephalitis virus activity in endemic southern India.

39. Flavivirus isolations from mosquitoes collected from Saibai Island in the Torres Strait, Australia, during an incursion of Japanese encephalitis virus.

40. Serosurveillance for Japanese encephalitis in children in several districts of West Bengal, India.

41. Mosquito host-feeding patterns and implications for Japanese encephalitis virus transmission in northern Australia and Papua New Guinea.

Catalog

Books, media, physical & digital resources